New Inert starter beads CELLETS® 150 by ingredientpharm

New Inert starter beads CELLETS® 150 by ingredientpharm
Product Description

We introduce CELLETS® 150, a new particle size for our pharmaceutical MCC spheres, ranging from 150-300 µm. State-of-the-art formulations with modified release profiles are often based on API carriers such as MCC pellets. CELLETS® are 100% MCC starter beads, offering unbeaten stability, sphericity, and surface smoothness for optimized coating of API and functional excipients. CELLETS® 150 are one of best choices for capsule, multiparticulate and dosage forms for special patient groups.

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC
Specifications
  • Details
    CELLETS® 150, a new particle size for our pharmaceutical MCC spheres, ranging from 150-300 µm.

    CELLETS® 150 are part of the CELLETS® product range. More information on www.cellets.com or by Bastian Arlt from ingredientpharm.
  • Selling Points
    Product Features
  • Model
    Excipients
  • Supplied from
    Germany
  • Measured In
    kilogram

Glatt Pharmaceutical Services GmbH & Co. K

  • DE
  • 2024
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Consultancy
Primary activities
Animal Health
Contract Manufacturer
Laboratory Services
OTC

More Products from Glatt Pharmaceutical Services GmbH & Co. K (5)

  • HyPearls®

    Product HyPearls®

    HyPearls® combine exfoliation and hydration in one stop. While exfoliation arises from the physical shape of the micro particle, hydration is based on the chemical properties of hyaluronic acid. The product can be incorporated in high quality cosmetic products. This allows for a significant increase in the...
  • Ibuprofen DC100

    Product Ibuprofen DC100

    Ibuprofen DC100 is pelletized ibuprofen consisting of 100% pure active without additional excipients. The high concentration of API provides maximum freedom in formulation of dosage forms e.g. tablet size and release characteristics to achieve better patients’ compliance. Complex Ibuprofen formulations res...
  • Formulation Development

    Product Formulation Development

    Formulation & process development of complex oral solids drug products. Specialized in solubility enhancement, drug delivery, controlled release, functional coating, granulation, pellets & micropellets. From technical feasibility to GMP for clinical trials and commercial manufacturing.Core compente...
  • Paediatric Formulation Development

    Product Paediatric Formulation Development

    Glatt Pharmaceutical Services specializes in the development of pediatric formulations tailored to meet the specific needs of children. Recognizing that children require different dosage forms and strengths, Glatt focuses on creating age-appropriate, safe, and effective medications. Our expertise includes ...
  • Solubility enhancement of poorly soluble drugs

    Product Solubility enhancement of poorly soluble drugs

    Amorphous Solid Dispersions via fluidbed granulation to achieve free flowing and direct compressible granules of the API in an amorphous form. This solution offers an optimized downstream process in comparision to the standard spray drying process.

    Glatt Pharmaceutical Services supports the formulat...

Glatt Pharmaceutical Services GmbH & Co. K resources (1)